» Articles » PMID: 22682188

Chromoblastomycosis

Overview
Journal Clin Dermatol
Publisher Elsevier
Specialty Dermatology
Date 2012 Jun 12
PMID 22682188
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Chromoblastomycosis is a chronic, subcutaneous mycosis, characterized by verrucous nodular lesions, usually involving the legs and mainly caused by Fonsecaea, Phialophora, and Cladophialophora spp. The characteristic finding on direct examination or biopsy specimen is the presence of fumagoid cells or Medlar bodies. Chromoblastomycosis can be refractory to medical treatment. Therapeutic options include oral itraconazole, terbinafine, or 5-fluocytosine, alone or combined with surgery or cryosurgery.

Citing Articles

An unusually subtle presentation of chromoblastomycosis.

Lau W, Damji Y, Orlowski G JAAD Case Rep. 2023; 40:11-13.

PMID: 37675069 PMC: 10477729. DOI: 10.1016/j.jdcr.2023.07.029.


Chromoblastomycosis: A case series from Eastern China.

Liu S, Zhi H, Shen H, Lv W, Sang B, Li Q PLoS Negl Trop Dis. 2022; 16(9):e0010800.

PMID: 36155495 PMC: 9536625. DOI: 10.1371/journal.pntd.0010800.


Biofilm Formation by Chromoblastomycosis Fungi and : Involvement with Antifungal Resistance.

Sousa I, Mello T, Pereira E, Granato M, Alviano C, Santos A J Fungi (Basel). 2022; 8(9).

PMID: 36135688 PMC: 9504689. DOI: 10.3390/jof8090963.


Presence of hyphae in chromoblastomycosis examinations: an enigma to be solved.

Carvalho G, de Camargo Votto Calbucci K, Lellis R, Veasey J An Bras Dermatol. 2021; 96(4):490-493.

PMID: 34006399 PMC: 8245724. DOI: 10.1016/j.abd.2020.09.008.


Unique Oral Presentations of Deep Fungal Infections: A Report of Four Cases.

Mutalik V, Bissonnette C, Kalmar J, McNamara K Head Neck Pathol. 2020; 15(2):682-690.

PMID: 32889592 PMC: 8134600. DOI: 10.1007/s12105-020-01217-0.